Hepatic ischemia/reperfusion upregulates the susceptibility of hepatocytes to confer the induction of inducible nitric oxide synthase gene expression

被引:38
作者
Yanagida, Hidesuke
Kaibori, Masaki
Yoshida, Hideyuki
Habara, Kozo
Yamada, Masanori
Kamiyama, Yasuo
Okumura, Tadayoshi
机构
[1] Kansai Med Univ, Dept Med Chem, Osaka 5708506, Japan
[2] Kansai Med Univ, Dept Surg, Osaka 5708506, Japan
来源
SHOCK | 2006年 / 26卷 / 02期
关键词
nitric oxide; inducible nitric oxide synthase; interleukin; 1; beta; nuclear factor kappa B; type; receptor;
D O I
10.1097/01.shk.0000223130.87382.73
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
During hepatic ischemia/reperfusion (I/R), proinflammatory cytokines such as tumor necrosis factor alpha and interleukin (IL) 1 beta stimulate the induction of inducible nitric oxide synthase (iNOS) in hepatocytes, followed by massive production of nitric oxide. We hypothesized that I/R upregulated the susceptibility of hepatocytes to confer the induction of iNOS gene expression. This study was designed to investigate whether cell susceptibility occurs in response to I/R and to delineate the mechanisms underlying the susceptibility. Hepatocytes were isolated from rats with hepatic I/R or sham, cultured, and treated with IL-1 beta. The iNOS induction and its signal including inhibitor kappa B (I kappa B) kinase/nuclear factor kappa B (NF-kappa B) and Akt/type 1 interleukin 1 receptor (IL-1R1) were analyzed. Hepatocytes isolated from rats with I/R markedly increased the production of nitric oxide when stimulated by IL-1 beta as compared with sham control. Ischemia/R also increased the levels of iNOS protein and its messenger RNA. Furthermore, I/R enhanced the activation of transcription factor NF-kappa B and the transactivation of iNOS promoter. However, I/R had no effects on the degradation Of I kappa B and the nuclear translocation of p65 subunit of NF-kappa B. In contrast, I/R increased the phosphorylation of Akt and the upregulation of IL-1R1 induction, which is essential signal for the transcriptional activation of iNOS in addition to I kappa B kinase/NF-kappa B. These results demonstrate that I/R may augment hepatocyte susceptibility for the induction of iNOS gene expression through the enhancement of IL-1R1.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 50 条
[1]   Cloning and sequencing of the proximal promoter of the rat iNOS gene: Activation of NF kappa B is not sufficient for transcription of the iNOS gene in rat mesangial cells [J].
Beck, KF ;
Sterzel, RB .
FEBS LETTERS, 1996, 394 (03) :263-267
[2]   IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription -: Requirement for an additional activation pathway [J].
Bergmann, M ;
Hart, L ;
Lindsay, M ;
Barnes, PJ ;
Newton, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :6607-6610
[3]   INDUCIBLE CYTOSOLIC ENZYME-ACTIVITY FOR THE PRODUCTION OF NITROGEN-OXIDES FROM L-ARGININE IN HEPATOCYTES [J].
BILLIAR, TR ;
CURRAN, RD ;
STUEHR, DJ ;
STADLER, J ;
SIMMONS, RL ;
MURRAY, SA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1034-1040
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Role of nitric oxide in liver injury [J].
Chen, T ;
Zamora, R ;
Zuckerbraun, B ;
Billiar, TR .
CURRENT MOLECULAR MEDICINE, 2003, 3 (06) :519-526
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159
[7]   ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN THE PATHOPHYSIOLOGIC ALTERATIONS AFTER HEPATIC ISCHEMIA REPERFUSION INJURY IN THE RAT [J].
COLLETTI, LM ;
REMICK, DG ;
BURTCH, GD ;
KUNKEL, SL ;
STRIETER, RM ;
CAMPBELL, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1936-1943
[8]   A cytokine-responsive IκB kinase that activates the transcription factor NF-κB [J].
Joseph A. DiDonato ;
Makio Hayakawa ;
David M. Rothwarf ;
Ebrahim Zandi ;
Michael Karin .
Nature, 1997, 388 (6642) :548-554
[9]   Molecular cloning of the rat inducible nitric oxide synthase gene promoter [J].
Eberhardt, W ;
Kunz, D ;
Hummel, R ;
Pfeilschifter, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 223 (03) :752-756
[10]  
GELLER DA, 1995, J IMMUNOL, V155, P4890